Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Jul 18, 2014 (12 years ago)

N-Acetyl Cysteine 20% 4 mL Vial Stock Code: 4133

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Non-Sterility: One lot of N-Acetyl Cysteine vials tested positive for Herbaspirillum huttiense.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

N-Acetyl Cysteine 20% 4 mL Vial Stock Code: 4133

Drug: Cysteine

Recalling firm
Unique Pharmaceutical, Ltd
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0011-2015 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Cysteine recalls

See all
Class II · Moderate risk

N-A-C

Mislabeling of SUS (N-A-C Sustain 600 mg 100 tab) with N-A-C N-Acetyl-L-Cysteine 500 mg, 100 cap.

Terminated Labeling / mix-up Jarrow Formulas Inc D-0302-2021

Other recalls by Unique Pharmaceutical, Ltd

All 2014 recalls
Class II · Moderate risk

All sterile products within expiry

Lack of Sterility Assurance: A recent FDA inspection revealed poor aseptic production practices that result in lack of sterility assurance of products intended to be sterile.

Terminated Sterility / contamination Unique Pharmaceutical, Ltd D-0012-2015